HDAC9 and early-onset autosomal dominant Alzheimer disease: Further to their primary use as anticancer agents, HDAC inhibitors have also proven to be important therapeutic drugs for a range of other diseases, including neurodegenerative disorders such as Alzheimer’s disease (AD) [106].